Dong Hui Yang
Fondateur chez Hangzhou Adlai Nortye Biopharma Co. Ltd.
Postes actifs de Dong Hui Yang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
 Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Directeur/Membre du Conseil | - | - |
| Fondateur | 01/01/2004 | - | |
| Corporate Officer/Principal | - | - |
Historique de carrière de Dong Hui Yang
Anciens postes connus de Dong Hui Yang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ADLAI NORTYE LTD. | Directeur/Membre du Conseil | 01/06/2018 | - |
| Corporate Officer/Principal | - | - |
Formation de Dong Hui Yang
| Jiangxi Normal University | Undergraduate Degree |
| South China Normal University | Graduate Degree |
Statistiques
Internationale
| Chine | 5 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sectorielle
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ADLAI NORTYE LTD. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Health Technology |
- Bourse
- Insiders
- Dong Hui Yang
- Expérience
